What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His main research concerns Alzheimer's disease, Neuroscience, Dementia, Pathology and Pittsburgh compound B.
Internal medicine and Disease are closely tied to his Alzheimer's disease research.
His research integrates issues of Prospective cohort study and Cognitive impairment in his study of Dementia.
Amyloid is closely connected to Positron emission tomography in his research, which is encompassed under the umbrella topic of Pathology.
His Pittsburgh compound B research incorporates elements of Dementia with Lewy bodies, Clinical Dementia Rating and Magnetic resonance imaging.
His Cognition research focuses on Hippocampus and how it connects with Hippocampal formation.
His most cited work include:
- Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease (2028 citations)
- New extended model of hadrons (1530 citations)
- Amyloid deposition is associated with impaired default network function in older persons without dementia (730 citations)
What are the main themes of his work throughout his whole career to date?
Keith A. Johnson spends much of his time researching Internal medicine, Neuroscience, Disease, Amyloid and Pathology.
His work in Cognitive decline, Alzheimer's disease and Dementia is related to Internal medicine.
The Cognitive decline study combines topics in areas such as Aging brain, Cognition and Neuropsychology.
Keith A. Johnson specializes in Alzheimer's disease, namely Pittsburgh compound B.
Neuroscience is frequently linked to Neurodegeneration in his study.
Many of his studies involve connections with topics such as Positron emission tomography and Amyloid.
He most often published in these fields:
- Internal medicine (22.70%)
- Neuroscience (18.90%)
- Disease (18.55%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (22.70%)
- Cognitive decline (15.46%)
- Disease (18.55%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cognitive decline, Disease, Cognition and Amyloid.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
The various areas that Keith A. Johnson examines in his Cognitive decline study include Alzheimer's disease, Positron emission tomography, Aging brain and Neuropsychology.
The subject of his Disease research is within the realm of Pathology.
While the research belongs to areas of Cognition, he spends his time largely on the problem of Depression, intersecting his research to questions surrounding Anxiety.
His work deals with themes such as Neuroscience and Activities of daily living, which intersect with Amyloid.
Between 2018 and 2021, his most popular works were:
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (148 citations)
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (148 citations)
- Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. (117 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Keith A. Johnson mainly focuses on Cognitive decline, Internal medicine, Cognition, Alzheimer's disease and Aging brain.
His Cognitive decline research includes elements of White matter, Pittsburgh compound B, Amyloid, Positron emission tomography and Cohort.
Amyloid is the subject of his research, which falls under Pathology.
In his research on the topic of Internal medicine, Longitudinal study and Prospective cohort study is strongly related with Oncology.
His studies deal with areas such as Cerebrospinal fluid and Cohort study as well as Alzheimer's disease.
Keith A. Johnson combines subjects such as Biomarker, Standardized uptake value and Neuroimaging with his study of Aging brain.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
